Your claims about your own capacity to self reflect are both self promoting and unverifiable. Save it for a psychology forum.
You like to write long dissertations. Case in point above. The sustained nature of the attacks and now ranking me compared with other posters...what is that? How am I to unpack this in a comprehensive way without being constantly diverted from the key topic?
Restating the same thing over and over doesn't make it more true.
Look at this logically:
- MSB is one of the most shorted stocks on the ASX.
- It's envitable that there are shorters in HC as the most popular chat site.
- Shorters are likely to post on a much more frequent basis than long term holders.
Result: distorted popularity polls. Result: a barrage of negative posts.
Onto the MSB-related issues now.
The use of the word 'may' is conditional.
The relevant factor is likelihood. What is the likelihood of MSB reaching a deal? You don't rate it at all. Resolutely you refuse to take on board the fact that MSB is in a stronger position by virtue of progress, fast tracking arrangements, including CHF being able to go to market in Japan based on Stage 2 clinical trials in the US plus a very small clinical trial. That's going to be very quick.
It takes a colossal effort to even begin to counter your constant barrage. I can only hope to offer hints and points for others to consider.
MSB have such a developed portfolio moving towards commercialisation.
MSB which has been thrashed by negative and misleading broker reports. Anyone who defends the company has to be prepared for an avalanche of attacks, personal and misleading.
What's new?
- Forums
- ASX - By Stock
- MSB
- anyone else conduct any due diligence on celgene?
anyone else conduct any due diligence on celgene?, page-18
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B |
Open | High | Low | Value | Volume |
$1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 23940 | $1.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.40 | 22571 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13940 | 1.390 |
1 | 14000 | 1.385 |
2 | 15350 | 1.370 |
2 | 20000 | 1.355 |
2 | 2400 | 1.350 |
Price($) | Vol. | No. |
---|---|---|
1.395 | 22571 | 2 |
1.400 | 108300 | 3 |
1.405 | 39000 | 3 |
1.410 | 1430 | 1 |
1.415 | 67966 | 3 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online